THE COMPANY

RESEARCH AND
DEVELOPMENT FOR
INNOVATIVE DEVICES

Airway Medix S.A. is focused intently on research and development in order to bring to market truly innovative devices for mechanically ventilated patients in intensive care units (ICUs), and for patients with life-threatening conditions being treated within anesthesiology departments.

MISSION
STATEMENT

We develop innovative medical devices that greatly improve patient care while reducing personnel workload in intensive care units, operating rooms, anesthesiology and home care.

Our devices are easily integrated into existing procedural protocols and are used worldwide by physicians and nurses to achieve unsurpassed patient safety, while boosting staff productivity and workflow efficiency.

We maintain the highest technological standards to ensure superior product quality and our streamlined and efficient manufacturing process enables us to offer our devices at very competitive prices.

Our solutions are protected by patents worldwide and based on unique know-how.

ABOUT US

Airway Medix S.A. is focused intently on research and development in order to bring to market truly innovative devices for mechanically ventilated patients in intensive care units (ICUs), and for patients treated within anesthesiology departments.

The family of products developed by Airway Medix is aimed at reducing the growth of biofilm in ventilated patients airways, reducing the microbial flora in the oral cavity, and improving the performance, integrity, application and fit of intubation tubes. By reducing biofilm formation and preventing entry of infected material into the lungs, the products aim at protecting patients from acquiring Ventilation Associated Pneumonia (VAP).

Ventilation Associated Pneumonia is considered one of the most dangerous and costly hospital-acquired infections. Large number of patients with VAP and the increase in overall intubation times underscores the deficiencies of devices currently available on the market. This is a prevalent problem in even the best hospitals, with serious consequences and challenges for both the patients and hospital

Products offered by Airway Medix address immediate clinical needs and the shortcomings of medical devices currently in use. They provide considerable clinical and economic benefits, reducing the workloads of staff, increasing the effectiveness of treatment protocols and, most importantly, improving overall patients’ performance and outcomes.

The Company conducts research and development work with its key distribution and manufacturing partners in Poland, Israel, Taiwan, Italy and Germany. In house and outsourced procedures and processes all comply with regulatory and certification standards of ISO 13485:2003 and EN ISO 13495:2012 and include :

• R&D PROCESSES
• PROTOTYPE DEVELOPMENT
• RELATIONSHIP AND ENGAGEMENT WITH MEDICAL SOCIETIES AND ASSOCIATIONS 
• CLINICAL TESTING AND HUMAN TRIALS
• QUALITY ASSURANCE
• LOW-SCALE PRODUCTION UNDER ISO
• REGULATORY PATHWAYS

Production is currently undertaken in Poland, one of top 5 manufacturing countries in the EU and an emerging innovator in efficient and high-quality production processes.

Milestones

MANAGEMENT

AIRWAY MEDIX IS RUN BY DRIVEN, HIGHLY QUALIFIED INDIVIDUALS WITH EXTENSIVE EXPERIENCE IN THE BIOSCIENCE SECTOR:

MAREK ORŁOWSKI

President of the Management Board

Co-Founder of Nepentes SA, a manufacturer and supplier of pharmaceuticals. After an IPO in 1997, the company was sold in 2010 to Sanofi-Aventis for over €100M. Since 2010, active as an angel investor in life-science companies in Poland and abroad.

PETER KRÖNER

Member of the Management Board

For over 25 years founder, owner and managing director of a medical company in consulting and medical care for doctor’s offices, therapy centers, purchasing associations, clinics and universities. Prior 15+ years in medical sales where Peter acquired expert knowledge and first-class connections. Based on his expertise, Peter Kröner represents leading German, Swiss, European and American manufacturers.

“Making medical products accessible that make everyday life in medical care and clinics much easier and sustainably improve the success of our customers”

ANNA ARANOWSKA-BABLOK

Member of the Management Board

Has 13 years of experience in the pharmaceutical and life-science industries and has served over 5 years in the C-Suite for a number of investment companies. Served on the boards of 10 life-science start-up companies. Has been involved in several companies at both the acquisition and start-up stages.

ORON ZACHAR

Inventor and co-founder

In charge of the portfolio development and intellectual property management strategy. Dr. Zachar is also an inventor and an entrepreneur. He earned his Ph.D. degree in theoretical physics at UCLA (U.S.) and has conducted research in France, Italy, and the United States. He is an author of several innovative solutions in such areas as optical memory technology, energy conversion technology, pharmacy, and medical devices development.

INTERNATIONAL PARTNERS

CURRENTLY WE HAVE SALES PARTNERSHIPS SET UP IN THE FOLLOWING COUNTRIES:

Our global reach is made possible through a network of dynamic sales partnerships that span the entire globe. This collaboration forms the foundation of our success and enables us to provide high-quality medical equipment and services worldwide, while preserving and enforcing local expertise and flexibility with regards to market responsiveness and optimal strategy adoption.

Currently we have sales partnerships set up in the following countries:

  • Italy
  • Poland
  • Brazil
  • Mexico
  • Ecuador
  • Australia
  • Spain
  • Switzerland
  • Korea
  • India
  • USA
  • Taiwan
  • Israel
  • Germany
  • UK

Our Business Development team is actively looking for new partnerships and is available at :